mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced  
Phone 01494 818 000
Current Jobs

Sales Specialist
Location: North East

Product Manager
Location: West Yorkshire

Territory Manager - Sports Medicine
Location: M62 Corridor

Regional Business Manager
Location: North East Region

Sales Specialist - PAS
Location: North East

Expert Trainer
Location: Mid UK

Field Sales Coach - Central
Location: Central UK

Senior Brand Manager
Location: Welwyn Garden City

Territory Manager - Sports Medicine
Location: South Central

Sales Specialist - MSS
Location: West Midlands

Centralised Diagnostics Sales Specialist
Location: South and Central London

Medical Advisor
Location: Princes Risborough, Bucks

Training Manager - Renal & Neurology and ELearnin
Location: Maidenhead, Berks

Training Manager - Part-time
Location: Maidenhead

Territory Manager - Sports Medicine
Location: West Scotland

Contraceptive pill use 'is not linked to a higher death rate'

Posted on 15/03/2010 in Medical Government/ NHS related news

Contraceptive pill users have been told that taking the medication does not increase their long-term risk of death.

A study in the British Medical Journal (BMJ) found that women in the UK who have used the oral contraceptive pill are less likely to die from any cause, including all cancers and heart disease, compared with those who have never taken it.

The results show a slightly higher risk of death in women under 45 who are current or recent users of the pill, but the authors stress that the effects in younger women disappear after about ten years.

However, the study also found that there continues to be a higher rate of violent or accidental death among oral contraceptive users, which the authors of the study were unable to explain.

Despite this, the authors concluded: "Oral contraception is not significantly associated with an increased long-term risk of death - indeed a net benefit was apparent."

Professor Philip Hannaford from the University of Aberdeen, who led the research, added that the findings are likely to be particularly reassuring to women who used the first generation of oral contraceptives.

Other news stories from 15/03/2010

Read more in the Zenopa News Archive

How this news is generated

Angela Robertson
QC/Training Consultant


Pharmaceutical Sales Jobs | Pharmaceutical Executive Jobs | Pharmaceutical Marketing Jobs | Medical Sales Jobs | Medical Devices Marketing Jobs | Medical Executive Jobs
Dental Sales Jobs | Veterinary Sales Jobs | Scientific Sales Jobs | Consumer Healthcare Sales Jobs | Consumer Healthcare Management Jobs | Medical Writing Jobs
Medical Writer Jobs | Healthcare PR Jobs | Animal Health Sales Jobs

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2012 Zenopa Ltd | terms & conditions of use